AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Greater vaccination coverage of groups at high risk of hepatitis B is needed in France to eradicate hepatitis B transmission.
According to recent research from France, "Both HBV plasma derived vaccines and HBV recombinant vaccines have proved safe and highly immunogenic. In France, exhaustive population surveys have revealed a vaccine coverage rate of over 21,7% and very low three-dose vaccine coverage among infants (19,8%), children (23,3%), and adolescents. Among hospital staff, around 80 to 90% of physicians and health care personnel in public or private hospitals were vaccinated against hepatitis B and the level of coverage was higher among personnel accidentally exposed to blood (90 to 100%)."
"Among risk groups, the specific prevention program against mother-infant transmission was unevenly applied, and between 25 to 45% of intravenous drug abusers, prisoners, or STD patients were vaccinated," reported Francois Denis at Limoges University and collaborators at Glaxo-Smith-Kline Laboratories. "These coverage rates are inadequate to obtain a significant reduction and control of hepatitis B ...